References:
1. Prachand VN, Milner R, Angelos P, et al. Medically necessary,
time-sensitive procedures: scoring system to ethically and efficiently
manage resource scarcity and provider risk during the COVID-19 pandemic.J Am Coll Surg . 2020. Aug;231(2):281-288
2. Farrington WJ, Mack CA, Karas MG, Ivascu NS, Robinson NB, Iannacone
E, Lau C, Mick SL, Girardi LN. New York’s perspective of COVID-19:
Effect and impact on cardiac surgery. J Card Surg. 2020 Sept 16; doi
10.1111/jocs.15043
3. Stahel PF. How to risk-stratify elective surgery during the COVID-19
pandemic? Patient Saf Surg . 2020. Mar
31;14:8.doi:10.1186/s13037-020-00235-9
4. Fisher B, Seese L, Ibrahim S, Kilic A. The importance of repeat
testing in detecting the coronavirus disease 2019 (COVID-19) in a
coronary artery bypass grafting patient. J Card Surg. 2020
Jun;35(6)1342-1344. doi: 10.1111/jocs.14604.
5. Lei S, Jiang F, Su W, et al. Clinical characteristics and outcomes of
patients undergoing surgeries during the incubation period of COVID-19
infection. EClinicalMedicine . 2020 Apr 5;21:100331. doi:
10.1016/j.eclinm.2020.100331.
6. Zeng J, Huang J, Pan L. How to balance acute myocardial infarction
and COVID-19: the protocols from Sichuan Provincial People’s Hospital.Intensive Care Med . 2020 Jun;46(6):1111-1113. doi:
10.1007/s00134-020-05993-9.
7. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic
complications in critically ill ICU patients with COVID-19. Thromb
Res . 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013.
8. Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe
hypercoagulability in patients admitted to intensive care unit for acute
respiratory failure. Thromb Haemost . 2020 Jun;50(1):223-226.
doi:10.1007/s11239-020-02160-1
9. Zhu H, Rhee J-W, Cheng P, et al. Cardiovascular complications in
patients with COVID-19: consequences of viral toxicities and host immune
response. Curr Cardiol Rep . 2020 Apr 21;22(5):32. doi:
10.1007/s11886-020-01292-3
.